A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine
Clinical trial NCT06615375 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06615375
- Sponsor
- LimmaTech Biologics AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-04-14
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.